IGC

0.283

0.53% 0.0015

Dopo l'orario di chiusura: .28 -0.003 -1.06%

IGC Pharma Inc (IGC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.2815

Aprire:

$0.289

Volume 24 ore:

615.03K

Relative Volume:

0.94

Capitalizzazione di mercato:

$29.26M

Reddito:

$1.27M

Utile/perdita netta:

$-7.12M

Rapporto P/E:

-5.4215

EPS:

-0.0522

Flusso di cassa netto:

$-5.28M

1 W Prestazione:

-5.19%

1M Prestazione:

+5.79%

6M Prestazione:

-0.70%

1 anno Prestazione:

-31.19%

Intervallo 1D:

$0.281

$0.2905

Intervallo di 1 settimana:

$0.281

$0.3027

Portata 52W:

$0.235

$0.4508

IGC Pharma Inc Stock (IGC) Company Profile

Nome

IGC Pharma Inc

Settore

Healthcare (1069)

Industria

Biotechnology (595)

Telefono

301-983-0998

Indirizzo

4336 Montgomery Avenue, Bethesda, MD

Dipendente

Cinguettio

@IGCIR

Prossima data di guadagno

2026-08-13

Ultimi documenti SEC

IGC's Discussions on Twitter

Compare IGC vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IGC IGC Pharma Inc	0.283	29.10M	1.27M	-7.12M	-5.28M	-0.0522
VRTX Vertex Pharmaceuticals Inc	514.56	132.08B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	793.26	83.15B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	984.04	62.71B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	136.62	54.14B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.35	44.51B	742.00K	-1.37B	-1.07B	-7.0731

IGC Pharma Inc Borsa (IGC) Ultime notizie

Sep 07, 2026

Price to earnings forward of IGC Pharma, Inc. – AMEX:IGC - TradingView

Sep 07, 2026

Sep 01, 2026

IGC Pharma (NYSE: IGC) Target Raised on Alzheimer's 2027 Outlook - marketscreener.com

Sep 01, 2026

Aug 27, 2026

Nasdaq 30's VIVS, IGC, RIME, AIXI Stocks Now - openPR.com

Aug 27, 2026

Aug 26, 2026

Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now - FinancialContent

Aug 26, 2026

Aug 24, 2026

IGC (IGC) Technicals: Falls 0.65% to $0.31 on the Day; Level Watch: $0.29 and $0.33 Define the Nearby Reference Levels in the Latest ReadingLarge Cap Trends - vinanet.vn

Aug 24, 2026

Aug 20, 2026

MicroCaps IGC, BIVI, ORBS, RIME Sub-$1 Stocks to Watch Now - openPR.com

Aug 20, 2026

Aug 18, 2026

IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com India

Aug 18, 2026

IGC (IGC) Earnings Data Review: The Bottom-Line Figure Outpaces Its Comparison at the Close; Session Reaction: Shares Move 1.43% Higher in the Current UpdatePost-Earnings Reaction - vinanet.vn

Aug 18, 2026

IGC Pharma earnings matched, revenue fell short of estimates - Investing.com

Aug 18, 2026

Aug 17, 2026

IGC Pharma Releases Q2 2026 Financial Results - AlphaStreet

Aug 17, 2026

VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum - openPR.com

Aug 17, 2026

IGC Pharma execs buy 4.27M shares to settle $1.15M debt - scanx.trade

Aug 17, 2026

IGC Pharma Q2 Results: Sales up 39% YoY, EPS loss widens to $(0.03) - scanx.trade

Aug 17, 2026

IGC Looks 24.1% Overvalued on GF Value™ - GuruFocus

Aug 17, 2026

IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure - Finviz

Aug 17, 2026

IGC Pharma Q2 Results: CALMA Nears Enrollment Closure - accessnewswire.com

Aug 17, 2026

Aug 14, 2026

IGC Pharma, Inc. 2026: Revenue $265K, EPS ($0.03) — 10-Q Summary - TradingView

Aug 14, 2026

IGC Pharma (NYSE: IGC) widens loss while Phase 2 Alzheimer’s trial hits key milestone - Stock Titan

Aug 14, 2026

IGC Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build - openPR.com

Aug 14, 2026

Aug 13, 2026

IGC Pharma (NYSE American:IGC): What Does the Latest Update Mean for Clinical Development? - Kalkine Media

Aug 13, 2026